Literature DB >> 22117506

Sarcoidosis and lymphoma: case series and literature review.

H Maayan1, Y Ashkenazi, A Nagler, G Izbicki.   

Abstract

This is a case series and literature review of patients with various types of hematologic disorders and sarcoidosis. The patients were treated in the hematologic day care unit at Shaare Zedek medical center and at the hematology department of Chaim Sheba Medical Center hospital from 1990 until 2008. We report eight cases from two centers where both diseases were diagnosed at different time points. We have shown that there might be coincidence of two rare conditions and emphasize the importance of tissues sampling of lesions suspected to be a relapse of a former biopsy-proven disease, even in the presence of positive PET results.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22117506

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  8 in total

1.  Clinical Characteristics of Sarcoidosis Patients with Self-Reported Lymphoma: A US Nationwide Registry Study.

Authors:  Bashar N Alzghoul; Yazan Zayed; Ahmad Obeidat; Bara Alzghoul; Abdallah Naser; Abdul-Rahim Shilbayeh; Ayoub Innabi; Tamara Al-Hakim; Mindy Buchanan; Borna Mehrad; Divya C Patel
Journal:  Lung       Date:  2021-10-19       Impact factor: 2.584

2.  Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions.

Authors:  Hussein Farghaly; Mohamed Alshareef; Abdullah Alqarni; Mohamed Sayed; Hatem Nasr
Journal:  Eur J Radiol Open       Date:  2020-09-07

3.  Clinical significance of post-treatment 18F-fluorodeoxyglucose uptake in cervical lymph nodes in patients with diffuse large B-cell lymphoma.

Authors:  Young-Sil An; Joon-Kee Yoon; Su Jin Lee; Seong Hyun Jeong; Hyun Woo Lee
Journal:  Eur Radiol       Date:  2016-05-18       Impact factor: 5.315

4.  Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.

Authors:  Michihiro Nakayama; Atsutaka Okizaki; Shunta Ishitoya; Miki Sakaguchi; Junichi Sato; Tamio Aburano
Journal:  Ann Nucl Med       Date:  2012-11-28       Impact factor: 2.668

5.  Dual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?

Authors:  Hussein Rabie Saleh Farghaly; Mohamed Hosny Mohamed Sayed; Hatem Ahmed Nasr; Ahmed Marzok Abdelaziz Maklad
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec

Review 6.  Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature.

Authors:  Jonathan London; Aurélie Grados; Christophe Fermé; Alexandre Charmillon; François Maurier; Bénédicte Deau; Etienne Crickx; Pauline Brice; Catherine Chapelon-Abric; Corinne Haioun; Barbara Burroni; Marco Alifano; Claire Le Jeunne; Loïc Guillevin; Nathalie Costedoat-Chalumeau; Nicolas Schleinitz; Luc Mouthon; Benjamin Terrier
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

7.  A sarcoidosis-lymphoma syndrome revealed by hypopituitarism.

Authors:  Charlotte Delcourt; Halil Yildiz; Alessandra Camboni; Eric Van den Neste; Véronique Roelants; Alexandra Kozyreff; Jean Paul Thissen; Dominique Maiter; Raluca Maria Furnica
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-09-27

8.  Sarcoidosis-Like Cancer-Associated Granulomatosis: Characteristics and a Case-Control Comparison with Sarcoidosis.

Authors:  Jean Pastré; Diane Bouvry; Karine Juvin; Amira Benattia; Isabella Annesi-Maesano; Dominique Valeyre; Hilario Nunes; Dominique Israël-Biet
Journal:  J Clin Med       Date:  2021-05-05       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.